Oncology Nursing News®
Oncology Nursing News CE
Current Issue
October 2018
View Past Issues
OncNurse TV
Precision Cancer Therapies Program Brings New Hope to Gulf Region
Precision Cancer Therapies Program Brings New Hope to Gulf Region
Nurse Leaders Incorporate More Kindness Into Their Work to Combat Burnout
Nurse Leaders Incorporate More Kindness Into Their Work to Combat Burnout
Tiki Barber: Oncology Nurses Are
Tiki Barber: Oncology Nurses Are "The Rock Patients Lean On"
View more >>

Oncology Nursing Articles

FDA Approves Glasdegib for First-Line Use in AML
FDA Approves Glasdegib for First-Line Use in AML
BY
FDA Approves Venetoclax for First-Line Use in AML
FDA Approves Venetoclax for First-Line Use in AML
BY
Epoetin Alfa Biosimilar Launched at Significant Discount in US
Epoetin Alfa Biosimilar Launched at Significant Discount in US
BY KRISTIE ROSA
Frontline Treatment of Metastatic NSCLC Depends on Biomarkers and Histology
Frontline Treatment of Metastatic NSCLC Depends on Biomarkers and Histology
BY ANITA T. SHAFFER
Prescribing Patterns of Opiate Use Among Patients with Cancer
Prescribing Patterns of Opiate Use Among Patients with Cancer
BY MINDY WAIZER
FDA Approves Eltrombopag Combo as First-Line Treatment for Severe Aplastic Anemia
FDA Approves Eltrombopag Combo as First-Line Treatment for Severe Aplastic Anemia
BY MINDY WAIZER
Building Disease Management Teams to Harness Clinical Trial Growth
Building Disease Management Teams to Harness Clinical Trial Growth
BY MINDY WAIZER
FDA Approves Brentuximab Vedotin for Frontline CD30+ Peripheral T-Cell Lymphoma
FDA Approves Brentuximab Vedotin for Frontline CD30+ Peripheral T-Cell Lymphoma
BY JASON M. BRODERICK
FDA Grants Breakthrough Designation to Brentuximab Vedotin for CD30+ PTCL
FDA Grants Breakthrough Designation to Brentuximab Vedotin for CD30+ PTCL
BY JASON M. BRODERICK
No Excuses--Talk to Your Patients About Sexuality After Cancer
No Excuses--Talk to Your Patients About Sexuality After Cancer
BY MINDY WAIZER
FDA Grants Priority Review to Atezolizumab Combination for Metastatic TNBC Subset
FDA Grants Priority Review to Atezolizumab Combination for Metastatic TNBC Subset
BY KRISTIE L. KAHL
FDA Grants Olaparib Priority Review for Frontline Maintenance in Ovarian Cancer
FDA Grants Olaparib Priority Review for Frontline Maintenance in Ovarian Cancer
BY JASON M. BRODERICK AND ANGELICA WELCH
View more >>
Latest Contributor Articles
Strategic Alliance Partnership
We've partnered with leading institutions to bring you the most recent findings in the field of oncology. Click below for offerings from our partners
 
Latest Advocacy News
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.